SCHEMBL31366714

SCHEMBL31366714

CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 17/20 0.62
▸ C5AR1 P21730 1/20 0.60
▸ IL23R Q5VWK5 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29936309 0.90 GLP1R (0.65) GLP1R
SCHEMBL29581449 0.87 GLP1R (0.66) GLP1RIL23R
SCHEMBL29641072 0.87 GLP1R (0.65) GLP1RIL23R
SCHEMBL29534029 0.87 IL23R (0.61) GLP1RC5AR1IL23R
SCHEMBL29581278 0.87 GLP1R (0.64) GLP1RIL23R
SCHEMBL29582112 0.87 GLP1R (0.64) GLP1RIL23R
SCHEMBL29461969 0.87 C5AR1 (0.61) GLP1RC5AR1IL23R
SCHEMBL31366758 0.87 GLP1R (0.58) GLP1RC5AR1IL23R
SCHEMBL29410268 0.87 IL23R (0.62) GLP1RC5AR1IL23R
SCHEMBL30037407 0.87 IL23R (0.61) GLP1RC5AR1IL23R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119431570-A Light chain and heavy chain variable region of anti-mycoplasma pneumoniae monoclonal antibody and application thereof 陕西省人民医院(陕西省临床医学研究院) 2025-02-14 — — CN claimed
CN-119431570-A Light chain and heavy chain variable region of anti-mycoplasma pneumoniae monoclonal antibody and application thereof 陕西省人民医院(陕西省临床医学研究院) 2025-02-14 — — CN disclosed
Send feedback